GlassScriptPhysician profile
Gregory A Pappas
NPI 1720040413
$379.93
in general payments reported to CMS, 2019-2025
12 companies · $37.55 in 2025
The $37.55 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.28 · 2020: $49.10 · 2021: $53.14 · 2023: $55.91 · 2024: $118 · 2025: $37.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $88.30 | 2023-2024 | |
| Abbott Laboratories | $53.14 | 2021 | |
| Abbvie INC. | $45.35 | 2019-2020 | |
| Astellas Pharma US INC | $41.92 | 2024-2025 | Veozah |
| Nevro Corp. | $25.48 | 2024 | Senza |
| Novo Nordisk INC | $22.49 | 2023 | Wegovy |
| Merck Sharp & Dohme LLC | $18.90 | 2019 | |
| Tactile Systems Technology INC | $18.32 | 2020 | |
| Olympus America INC. | $17.40 | 2019 | |
| Exact Sciences Corporation | $17.19 | 2025 | The Cologuard Plus Collection Kit |
| Agile Therapeutics, INC. | $16.03 | 2023 | Twirla |
| Hologic Sales and Service, LLC | $15.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Pappas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.